Quinazolinediones And Their Use

Abstract

The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts or prodrugs thereof, which inhibit the poly(ADP-ribose) polymerases (PARP) and therefore are useful for treating diseases, disorders, and conditions related to PARP. The present invention also discloses pharmaceutical compositions comprising a compound of formula (I), and methods of using such compounds to inhibit PARP enzymes, and to treat diseases, disorders, and conditions related to PARP.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 28, 2015
  • Application: Mar 12, 2012
    US US 201214004633 A
  • Priority: Mar 12, 2012
    US US 201214004633 A
  • Priority: Mar 12, 2012
    US US 2012/0028698 W
  • Priority: Mar 14, 2011
    US US 201161452360 P

Download Citation


Sign in to the Lens

Feedback